flâneur

Multiply Labs | Robotic Biomanufacturing Infrastructure

multiplylabs.com · 1,197 words · saved by 3 readers

Our robots are making sure that 'too expensive' and 'not enough' no longer stand between a patient and their cure. The next generation of biological drugs is showing incredible promise in terms of safety and efficacy. The science is working. But the manufacturing stack, built decades ago for small molecules and large batches, was never designed for the complexity, precision, and throughput that advanced therapies now demand. What worked for the last generation of pharma can't work for the next. Through imitiation learning, parallel orchestration, and real-time monitoring, our robots enable your existing instrument ecosystem to scale. When demand doubles, deploy another cluster, scaling throughput without increasing process complexity. The Cluster connects your existing GMP instruments inside a closed, automated environment. Your process stays the same. Your throughput increases by up to 100x, and costs decrease by 74%. Biologics manufacturing is made up of dozens of discrete unit opera

Physical AI for biological manufacturing Our robots are making sure that 'too expensive' and 'not enough' no longer stand between a patient and their cure. Announced Collaborations Technology Partners Instrument Partners The Biomanufacturing Problem Patients are waiting for advanced therapies. The factory floors are not ready. The next generation of biological drugs is showing incredible promise in terms of safety and efficacy. The science is working. But the manufacturing stack, built decades ago for small molecules and large batches, was never designed for the complexity,…

saved by

related reading